Cover Image
Market Research Report

3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Skin, Drug Research), End user (Biopharma, Academia) - Global Forecast to 2024

Published by MarketsandMarkets Product code 432880
Published Content info 184 Pages
Delivery time: 1-2 business days
Price
Back to Top
3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Skin, Drug Research), End user (Biopharma, Academia) - Global Forecast to 2024
Published: October 1, 2019 Content info: 184 Pages
Description

"The 3D bioprinting market is projected to grow at a CAGR of 20.4% during the forecast period."

The 3D bioprinting market is projected to reach USD 1,647 million by 2024 from USD 651 million in 2019, at a CAGR of 20.4% from 2019 to 2024. The growth in this market is mainly driven by technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities. On the other hand, a shortage of skilled professionals and high development and production costs are hampering the growth of this market.

"Microextrusion technology commanded the largest share of 3D bioprinters segment owing to technological advancements."

The component segment of 3D bioprinting market is segmented into 3D bioprinters and bioinks. The 3D bioprinters market is further sub-segmented on the basis of technology into magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting, microextrusion bioprinting, and other technologies; whereas bioinks segment is further sub-segmented into natural, synthetic, and hybrid bioinks. The microextrusion bioprinting technology has commanded the largest share of the market in 2019 due to technological advancements in the segment and the increasing research activities.

"The drug discovery research application segment accounted for the largest share of the 3D bioprinting market in 2019."

In terms of applications, the 3D bioprinting market is segmented into research applications and clinical applications. The demand for research applications is further sub-segmented into drug research, regenerative medicine, and 3D cell culture. Among these, the drug research segment accounted for the largest share of the market in 2019, owing to the growing adoption of the 3D bioprinting technology by biopharmaceutical companies. While, in terms of clinical applications, the market is segmented into skin, bone & cartilage, blood vessels, and other clinical applications.

"Based on material, living cells segment commanded the leading market share in 2019"

Based on material, the 3D bioprinting market is broadly segmented into hydrogels, extracellular matrices, living cells, and other biomaterials. Increasing R&D activities for the use of living cells in 3D bioprinting is driving the growth of the living cells segment. Living cells have the ability to fabricate patient-specific tissues in a defined manner. With advances in 3D bioprinting, scientists and researchers are making use of living cells as a biomaterial in 3D bioprinting. These cells can be used to print living tissues as well as organ structures for surgical implantations. However, ethical issues associated with the use of stem cells in 3D bioprinting might hamper growth of the segment.

"The US 3D bioprinting market to hold prominent market share over the forecast period."

On the basis of region, the 3D bioprinting market is segmented into North America, Europe, Asia Pacific, and Rest of the World (Latin America, and the Middle East and Africa). The US held the significant share of the global 3D bioprinting market in 2019. Factors such as new product launches and technological advancements in 3D bioprinting technology and the presence of key players in the region are driving the growth of the 3D bioprinting market in the US. Moreover, extensive research activities and funding for 3D bioprinting will further fuel the market growth in the US.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 - 45%, Tier 2 - 35%, and Tier 3 - 20%
  • By Designation: C-level - 26%, Director-level - 30%, and Others - 44%
  • By Region: North America- 34%, Europe - 26%, APAC - 23%, and RoW - 17%

The major players in the market include: Organovo Holdings Inc. (US), CELLINK (Sweden), Allevi Inc. (US), Aspect Biosystems Ltd. (Canada), EnvisionTEC GmbH (Germany), Cyfuse Biomedical K.K. (Japan), Poietis (France), TeVido BioDevices (US), Nano3D Biosciences, Inc. (US), ROKIT Healthcare (South Korea), Digilab Inc. (US), regenHU (Switzerland), GeSiM (Germany), Advanced Solutions Life Sciences (US), and Regenovo Biotechnology Co., Ltd. (China) among others.

Research Coverage:

This report studies the 3D bioprinting market based on component, application, material, end-user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning individual growth trends, and it also forecasts the revenue of the market segments for four main region.

Key Benefits of Buying the Report:

This report focuses on various levels of analysis-industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; and high-growth countries along with their respective drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Table of Contents
Product Code: BT 4971

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2 PRIMARY RESEARCH VALIDATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 3D BIOPRINTING MARKET OVERVIEW
  • 4.2 3D BIOPRINTING MARKET SHARE, BY COMPONENT AND REGION
  • 4.3 3D BIOPRINTING MARKET, BY MATERIAL, 2019 VS. 2024 (USD MILLION)
  • 4.4 3D BIOPRINTING MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • 4.5 GEOGRAPHIC SNAPSHOT OF THE 3D BIOPRINTING MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 3D BIOPRINTING APPROACHES
    • 5.2.1 BIOMIMICRY
    • 5.2.2 AUTONOMOUS SELF-ASSEMBLY
    • 5.2.3 MINI-TISSUE BUILDING BLOCKS
  • 5.3 MARKET DYNAMICS
    • 5.3.1 DRIVERS
      • 5.3.1.1 Increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries
      • 5.3.1.2 Rising public and private funding to support bioprinting research activities
      • 5.3.1.3 Technological advancements in the 3D bioprinting industry
    • 5.3.2 RESTRAINTS
      • 5.3.2.1 Dearth of skilled professionals
      • 5.3.2.2 High development & production costs
      • 5.3.2.3 Lack of regulatory guidelines governing 3D bioprinting
    • 5.3.3 OPPORTUNITIES
      • 5.3.3.1 Rising demand for organ transplants
      • 5.3.3.2 Growing awareness of 3D bioprinting
      • 5.3.3.3 Growing demand for regenerative medicine & stem cell research
    • 5.3.4 CHALLENGES
      • 5.3.4.1 Socioethical concerns related to the use of 3D bioprinted products
      • 5.3.4.2 High cost of 3D bioprinting
      • 5.3.4.3 Process control & understanding

6 3D BIOPRINTING MARKET, BY COMPONENT

  • 6.1 INTRODUCTION
  • 6.2 3D BIOPRINTERS
    • 6.2.1 3D BIOPRINTERS MARKET, BY TECHNOLOGY
      • 6.2.1.1 Microextrusion bioprinting
        • 6.2.1.1.1 Increasing research in the field of microextrusion is fueling the adoption of this technology
      • 6.2.1.2 Inkjet 3D bioprinting
        • 6.2.1.2.1 High cell viability and low cost have resulted in the increased demand for inkjet 3D bioprinting
      • 6.2.1.3 Laser-assisted bioprinting
        • 6.2.1.3.1 Laser-assisted bioprinting is one of the highest-resolution bioprinting technologies available in the 3D bioprinting industry
      • 6.2.1.4 Magnetic 3D bioprinting
        • 6.2.1.4.1 Accuracy and speed in the formation and processing of cultured tissues are the major advantages associated with magnetic 3D bioprinting
      • 6.2.1.5 Other technologies
  • 6.3 BIOINKS
    • 6.3.1 NATURAL BIOINKS
      • 6.3.1.1 Natural bioinks are the most commonly preferred bioinks in the 3D bioprinting process
    • 6.3.2 HYBRID BIOINKS
      • 6.3.2.1 Hybrid bioinks possess high mechanical strength and great biocompatibility
    • 6.3.3 SYNTHETIC BIOINKS
      • 6.3.3.1 Improved mechanical strength and consistency offered by synthetic bioinks to drive market growth

7 3D BIOPRINTING MARKET, BY MATERIAL

  • 7.1 INTRODUCTION
  • 7.2 LIVING CELLS
    • 7.2.1 ETHICAL ISSUES ASSOCIATED WITH THE USE OF LIVING CELLS IN ORGAN DEVELOPMENT TO HAMPER MARKET GROWTH
  • 7.3 HYDROGELS
    • 7.3.1 DYNAMIC PROPERTIES OF HYDROGELS ARE SUPPORTING THEIR INCREASED USE IN 3D TISSUE ENGINEERING AND BIOMEDICAL APPLICATIONS
  • 7.4 EXTRACELLULAR MATRICES
    • 7.4.1 ECM HAS EMERGED AS A PROMISING TOOL IN TISSUE ENGINEERING
  • 7.5 OTHER BIOMATERIALS

8 3D BIOPRINTING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 RESEARCH APPLICATIONS
    • 8.2.1 DRUG RESEARCH
      • 8.2.1.1 Drug research segment to register the highest growth during the forecast period
    • 8.2.2 REGENERATIVE MEDICINE
      • 8.2.2.1 Growing demand for organ transplants to support market growth
    • 8.2.3 3D CELL CULTURE
      • 8.2.3.1 Rising focus on developing alternatives to animal testing to support market growth
  • 8.3 CLINICAL APPLICATIONS
    • 8.3.1 SKIN
      • 8.3.1.1 Growing number of aesthetic and reconstruction surgeries to propel market growth
    • 8.3.2 BONE & CARTILAGE
      • 8.3.2.1 Increasing incidence of musculoskeletal conditions to drive the demand for bone grafts
    • 8.3.3 BLOOD VESSELS
      • 8.3.3.1 Increasing research activities focused on the 3D bioprinting of blood vessels is the major factor driving market growth
    • 8.3.4 OTHER CLINICAL APPLICATIONS

9 3D BIOPRINTING MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 RESEARCH ORGANIZATIONS & ACADEMIC INSTITUTES
    • 9.2.1 RESEARCH ORGANIZATIONS & ACADEMIC INSTITUTES ARE THE FASTEST-GROWING END USERS OF 3D BIOPRINTING
  • 9.3 BIOPHARMACEUTICAL COMPANIES
    • 9.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE THE ADOPTION OF 3D BIOPRINTING AMONG BIOPHARMACEUTICAL COMPANIES
  • 9.4 HOSPITALS
    • 9.4.1 3D PRINTING OFFERS A CUSTOMIZED SURGICAL PLANNING TOOL FOR HOSPITALS

10 3D BIOPRINTING MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 The US dominates the global 3D bioprinting market
    • 10.2.2 CANADA
      • 10.2.2.1 Government initiatives to support the growth of the 3D bioprinting market in Canada
  • 10.3 EUROPE
    • 10.3.1 GERMANY
      • 10.3.1.1 Increasing demand for organ transplants to drive market growth
    • 10.3.2 UK
      • 10.3.2.1 Increase in funding and grants to support research activities related to 3D bioprinting in the UK
    • 10.3.3 FRANCE
      • 10.3.3.1 Growing cosmetics industry in France to propel the adoption of 3D bioprinting technologies
    • 10.3.4 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 JAPAN
      • 10.4.1.1 Strong research base and government support to drive the growth of the 3D bioprinting market in Japan
    • 10.4.2 CHINA
      • 10.4.2.1 The market in China is projected to register significant growth owing to rising regenerative medicine research
    • 10.4.3 INDIA
      • 10.4.3.1 Initiatives to raise awareness and develop novel products to support market growth in India
    • 10.4.4 REST OF ASIA PACIFIC
  • 10.5 REST OF THE WORLD
    • 10.5.1 LATIN AMERICA
      • 10.5.1.1 Growing medical tourism to contribute to the growth of the 3D bioprinting market in the region
    • 10.5.2 MIDDLE EAST & AFRICA
      • 10.5.2.1 Lack of awareness and underdeveloped infrastructure to hamper market growth

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 MARKET RANKING ANALYSIS
  • 11.3 COMPETITIVE SCENARIO
  • 11.4 COMPETITIVE LEADERSHIP MAPPING
  • 11.5 VENDOR INCLUSION CRITERIA
  • 11.6 VENDOR DIVE
    • 11.6.1 VISIONARY LEADERS
    • 11.6.2 INNOVATORS
    • 11.6.3 DYNAMIC DIFFERENTIATORS
    • 11.6.4 EMERGING COMPANIES

12 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 12.1 ADVANCED SOLUTIONS LIFE SCIENCES
  • 12.2 ALLEVI INC.
  • 12.3 ASPECT BIOSYSTEMS LTD.
  • 12.4 CELLINK
  • 12.5 CYFUSE BIOMEDICAL K.K.
  • 12.6 DIGILAB, INC.
  • 12.7 ENVISIONTEC
  • 12.8 GESIM
  • 12.9 NANO3D BIOSCIENCES, INC.
  • 12.10 ORGANOVO HOLDINGS, INC.
  • 12.11 POIETIS
  • 12.12 REGENHU
  • 12.13 REGENOVO BIOTECHNOLOGY CO., LTD.
  • 12.14 ROKIT HEALTHCARE
  • 12.15 TEVIDO BIODEVICES

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 2: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 3: 3D BIOPRINTERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 4: MICROEXTRUSION BIOPRINTING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5: INKJET 3D BIOPRINTING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: LASER-ASSISTED BIOPRINTING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: MAGNETIC 3D BIOPRINTING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 10: BIOINKS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: NATURAL BIOINKS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: HYBRID BIOINKS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: SYNTHETIC BIOINKS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 15: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: 3D BIOPRINTING MARKET FOR HYDROGELS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 20: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 21: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 23: 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 25: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 26: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 27: 3D BIOPRINTING MARKET FOR SKIN PRINTING APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: 3D BIOPRINTING MARKET FOR BONE & CARTILAGE PRINTING APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: 3D BIOPRINTING MARKET FOR BLOOD VESSEL PRINTING APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: LIST OF ONGOING CLINICAL TRIALS
  • TABLE 31: 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 33: 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS & ACADEMIC INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 34: 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 35: 3D BIOPRINTING MARKET FOR HOSPITALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 36: 3D BIOPRINTING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 37: NORTH AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 38: NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 39: NORTH AMERICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 40: NORTH AMERICA: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 41: NORTH AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 42: NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 43: NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 44: NORTH AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 45: NORTH AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 46: US: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 47: US: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 48: US: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 49: US: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 50: US: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 51: US: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 52: US: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 53: US: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 54: CANADA: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 55: CANADA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 56: CANADA: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 57: CANADA: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 58: CANADA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 59: CANADA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 60: CANADA: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 61: CANADA: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 62: EUROPE: 3D BIOPRINTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 63: EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 64: EUROPE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 65: EUROPE: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 66: EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 67: EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 68: EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 69: EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 70: EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 71: GERMANY: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 72: GERMANY: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 73: GERMANY: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 74: GERMANY: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 75: GERMANY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 76: GERMANY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 77: GERMANY: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 78: GERMANY: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 79: UK: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 80: UK: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 81: UK: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 82: UK: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 83: UK: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 84: UK: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 85: UK: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 86: UK: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 87: FRANCE: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 88: FRANCE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 89: FRANCE: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 90: FRANCE: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 91: FRANCE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 92: FRANCE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 93: FRANCE: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 94: FRANCE: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 95: ROE: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 96: ROE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 97: ROE: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 98: ROE: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 99: ROE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 100: ROE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 101: ROE: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 102: ROE: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 103: ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 104: ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 105: ASIA PACIFIC: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 106: ASIA PACIFIC: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 107: ASIA PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 108: ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 109: ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 110: ASIA PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 111: ASIA PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 112: JAPAN: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 113: JAPAN: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 114: JAPAN: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 115: JAPAN: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 116: JAPAN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 117: JAPAN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 118: JAPAN: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 119: JAPAN: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 120: CHINA: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 121: CHINA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 122: CHINA: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 123: CHINA: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 124: CHINA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 125: CHINA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 126: CHINA: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 127: CHINA: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 128: INDIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 129: INDIA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 130: INDIA: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 131: INDIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 132: INDIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 133: INDIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 134: INDIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 135: INDIA: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 136: ROAPAC: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 137: ROAPAC: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 138: ROAPAC: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 139: ROAPAC: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 140: ROAPAC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 141: ROAPAC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 142: ROAPAC: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 143: ROAPAC: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 144: REST OF THE WORLD: 3D BIOPRINTING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 145: REST OF THE WORLD: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 146: REST OF THE WORLD: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 147: REST OF THE WORLD: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 148: REST OF THE WORLD: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 149: REST OF THE WORLD: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 150: REST OF THE WORLD: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 151: REST OF THE WORLD: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 152: REST OF THE WORLD: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 153: LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 154: LATIN AMERICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 155: LATIN AMERICA: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 156: LATIN AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 157: LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 158: LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 159: LATIN AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 160: LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 161: MIDDLE EAST & AFRICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 162: MIDDLE EAST & AFRICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 163: MIDDLE EAST & AFRICA: 3D BIOINKS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 164: MIDDLE EAST & AFRICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 165: MIDDLE EAST & AFRICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 166: MIDDLE EAST & AFRICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 167: MIDDLE EAST & AFRICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2017-2024 (USD MILLION)
  • TABLE 168: MIDDLE EAST & AFRICA: 3D BIOPRINTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 169: PRODUCT LAUNCHES & APPROVALS
  • TABLE 170: COLLABORATIONS
  • TABLE 171: EXPANSIONS
  • TABLE 172: ACQUISITIONS

LIST OF FIGURES

  • FIGURE 1: 3D BIOPRINTING MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARIES
  • FIGURE 4: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 5: MARKET SIZE ESTIMATION: OVERALL 3D BIOPRINTING MARKET
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: 3D BIOPRINTING MARKET SHARE, BY COMPONENT, 2019 VS. 2024
  • FIGURE 8: 3D BIOPRINTING MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: 3D BIOPRINTING MARKET SHARE, BY MATERIAL, 2019 VS. 2024
  • FIGURE 10: 3D BIOPRINTING MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT OF THE 3D BIOPRINTING MARKET
  • FIGURE 12: TECHNOLOGICAL ADVANCEMENTS IN 3D BIOPRINTERS AND BIOMATERIALS TO DRIVE MARKET GROWTH
  • FIGURE 13: NORTH AMERICA IS THE LARGEST REGIONAL MARKET FOR 3D BIOPRINTERS AND BIOINKS
  • FIGURE 14: LIVING CELLS SEGMENT TO HOLD THE MAJOR SHARE OF THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: RESEARCH ORGANIZATIONS & ACADEMIC INSTITUTES WILL REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 16: CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 17: 3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT
  • FIGURE 19: EUROPE: 3D BIOPRINTING MARKET SNAPSHOT
  • FIGURE 20: ASIA PACIFIC: 3D BIOPRINTING MARKET SNAPSHOT
  • FIGURE 21: GLOBAL 3D BIOPRINTING MARKET RANKING, BY KEY PLAYER, 2018
  • FIGURE 22: COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET), 2018
  • FIGURE 23: COMPETITIVE LEADERSHIP MAPPING (SME/START-UPS), 2018
  • FIGURE 24: CELLINK: COMPANY SNAPSHOT
  • FIGURE 25: ORGANOVO HOLDINGS, INC.: COMPANY SNAPSHOT
Back to Top